IT之家 1 月 23 日消息，旧金山生物科技公司 Retro Biosciences 正在筹集 10 亿美元资金， 用于支持其通过人工智能（AI）技术延长人类寿命 10 年的使命 。该公司计划今年将其首款药物推进临床试验阶段。

Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...

Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's ...

President Donald Trump took to the podium once again to reveal a significant investment targeting Artificial Intelligence ...

Accredited investors can become the landlord of Walmart, Whole Foods or Kroger — and benefit from regular distributions ...

Sam Altman's OpenAI is backing a new AI initiative from a group where John Kerry was a founding member that has voiced ...